Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-096606
Filing Date
2023-08-30
Accepted
2023-08-29 18:27:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2320798-3_424b3.htm 424B3 9494
2 GRAPHIC lg_eyenovia-4clr.jpg GRAPHIC 83523
  Complete submission text file 0001104659-23-096606.txt   122002
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-261638 | Film No.: 231223388
SIC: 2834 Pharmaceutical Preparations